Turku, Finland

Teppo Riihimäki

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Schering Oy. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teppo Riihimäki. Retrieved from https://idiyas.com/inventor/teppo-riihimäki-n8u1eq4j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teppo Riihimäki: Innovator in Delivery Systems

Introduction

Teppo Riihimäki is a notable inventor based in Turku, Finland. He has made significant contributions to the field of delivery systems, particularly in the pharmaceutical industry. His innovative approach has led to the development of a unique delivery system that enhances the efficacy of therapeutically active agents.

Latest Patents

Teppo Riihimäki holds a patent for a delivery system that comprises a core and a membrane encasing said core. This system is characterized by an elastomer composition, where the core contains at least one therapeutically active agent. The membrane includes at least one regulating agent, which plays a crucial role in controlling the release of the active agent. This invention represents a significant advancement in drug delivery technology.

Career Highlights

Throughout his career, Teppo Riihimäki has worked with prominent companies in the pharmaceutical sector. He has been associated with Schering Oy and Bayer Schering Pharma AG, where he contributed to various projects aimed at improving drug delivery mechanisms. His experience in these organizations has enriched his expertise in the field.

Collaborations

Due to space constraints, the collaborations section has been omitted.

Conclusion

Teppo Riihimäki's innovative work in delivery systems showcases his commitment to advancing pharmaceutical technology. His patent reflects a significant step forward in the effective delivery of therapeutically active agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…